{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:19:11Z","timestamp":1780118351398,"version":"3.54.0"},"reference-count":24,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s284959","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:19:16Z","timestamp":1609967956000},"page":"9-18","source":"Crossref","is-referenced-by-count":16,"title":["An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-7507","authenticated-orcid":true,"given":"Richard F","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorden","family":"Muduma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","volume":"6","author":"Kaitha","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2019.22450","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1182\/blood-2018-99-114386","volume":"132","author":"Emrich","year":"2018","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/apt.15386","volume":"50","author":"Detlie","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","volume":"95","author":"Bonovas","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.14043","volume":"45","author":"Aksan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1080\/17425247.2017.1393412","volume":"14","author":"Pollock","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s12325-018-0827-5","volume":"35","author":"Pollock","year":"2018","journal-title":"Adv Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ajg.2009.114","volume":"104","author":"Kulnigg","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4585164","DOI":"10.1155\/2017\/4585164","volume":"2017","author":"Frigstad","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"ref12","unstructured":"Hoivik ML, Moum B, Glomsaker R Inflammatory bowel disease in Norway 1999 to 2014: increasing prevalence and local geographical differences. Abstract P693 presented at the 11th Congress of ECCO - European Crohn\u2019s and Colitis Organisation; 2016."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/apt.12528","volume":"39","author":"B\u00fcsch","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3109\/00365521.2010.485323","volume":"45","author":"Manninen","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.MIB.0000442728.74340.fd","volume":"20","author":"Filmann","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"key":"ref17","unstructured":"Kuopion Yliopistollisen Sairaalan. Kliinisten Erikoisalojen Palvelutuotteet, Suoritteeet Ja Hinnat. 2019. Available from: https:\/\/www.psshp.fi\/documents\/7796350\/7869509\/Klinikkahinnasto+2019.pdf. Accessed July 23, 2020."},{"key":"ref18","unstructured":"Helsedirektoratet. Innsatsstyrt finansiering (ISF) \u2013 regelverk. Available from: https:\/\/www.helsedirektoratet.no\/tema\/finansiering\/innsatsstyrt-finansiering-og-drg-systemet\/innsatsstyrt-finansiering-isf. Accessed July 23, 2020."},{"key":"ref19","unstructured":"Dawa Kabiru K, Maw F, Johnson M, Dhar A, Pollock R. Resource utilization and costs associated with intravenous iron infusions in patients with inflammatory bowel disease and iron deficiency anemia or hypoferritinemia: real-world evidence from the UK. Abstract and poster P1485 at United European Gastroenterology Week Virtual 2020; October 11\u201313, 2020."},{"key":"ref20","unstructured":"American Regent, Inc. INJECTAFER\u00ae (ferric carboxymaltose injection) prescribing information. Revised February 2020. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203565s009lbl.pdf. Accessed July 24, 2020."},{"key":"ref21","unstructured":"European Medicines Agency Pharmacovigilance Risk Assessment Committee. Assessment Report on the PSUR(s) for iron (parenteral preparations, except for iron dextran) Annex I. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/iron-parenteral-preparations-except-iron-dextran-cmdh-scientific-conclusions-grounds-variation\/00010236\/202001_en.pdf. Accessed September 25, 2020."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/17474086.2020.1709437","volume":"13","author":"Pollock","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"ref23","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research. Injectafer (ferric carboxymaltose) medical review. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/203565Orig1s000MedR.pdf. Accessed July 24, 2020."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa126","author":"Grunert","year":"2020","journal-title":"J Crohns Colitis"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65466","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=65466","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:19:25Z","timestamp":1609967965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/an-economic-analysis-of-ferric-derisomaltose-versus-ferric-carboxymalt-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2147\/ceor.s284959","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}